BHS Myeloma Committee event : Optimising the use of bispecific antibodies in multiple myeloma

Hof ter Musschen


Avenue E. Mounier 2, 1200 Brussels


15 March 2024

More information will follow

Online registration is open

The BHS Myeloma Committee is pleased to invite hematologists, hematologists-in-training, and nurse specialists to their symposium on "Optimising the use of bispecific antibodies in multiple myeloma" to be held on Friday, 15 March in Hof ter Musschen (Brussels).

Register Here

Final Program:

13:45-14:00: Onsite registration

14:00-14:05: Welcome and Introduction (Chair: Michel Delforge, UZ Leuven)

Part 1: BCMA targeting agents (Chair: Nathalie Meuleman, HUB Institut Jules Bordet)

14:05 - 14:30: Clinical results with BCMA targeting bispecifics (Julien Depaus, CHU UCL Namur, site Godinne)

14:30 – 15:00: Managing side effects of BCMA targeting bispecifics (Michel Delforge, UZ Leuven)

15:00 – 15:20: Panel discussion

15:20 – 15:45: Coffee break 

Part 2: Other targets (Chair: Marie-Christiane Vekemans, UCLouvain Saint-Luc)

15:45 - 16:15: Clinical results with non-BCMA targeting bispecifics (Jo Caers, CHU Liège)

16:15 – 16:45: Managing side effects of non-BCMA targeting bispecfics (Nicolas Kint, UZ Gent)

16:45 – 17:15: Panel discussion including therapeutic strategies post-bispecific treatment

17:30: Closure